Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
16, 2016 /CNW/ - Eli Lilly Canada announced the approval of Trulicity (dulaglutide), a once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist indicated for the treatment of adults with type 2 diabetes to improve glycemic control
It causes the release of endogenous (internal) Growth Hormone (GH) from somatotropes in the anterior pituitary gland
Injection technique and timing Proper injection technique affects both comfort and absorption
Although kidney-related side effects are uncommon, staying vigilant is particularly important if you have a history of kidney issues
US$ 28.22
US$ 28.69
US$ 27.31
